Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0, a site version/UI change that does not modify study details.
    Difference
    0.1%
    Check dated 2026-03-19T23:41:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this appears to be a minor metadata update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-12T19:36:40.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma and Fallopian tube cancer to the study's Conditions, and updated the page version from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:21:50.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no user-facing content changes were observed.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:43.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Glossary display has been added, and a new 'Last Update Submitted that Met QC Criteria' indicator appears, along with a 'No FEAR Act Data' notice and a revision banner for v3.4.0. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' information has been removed.
    Difference
    0.2%
    Check dated 2026-01-28T20:29:04.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no changes to study details or content.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:01.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.